Re: BIO Investor Forum, Oct 22-23

No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BIO Investor Forum, Oct 22-23

in response to

Re: BIO Investor Forum, Oct 22-23

narmac

posted on Oct 24, 2019 04:18PM

I just went on the ZE site and the presentation is there. I haven't had a chance to look at it.